Efficacy and Safety of Nemolizumab in Subjects With Moderate-to-Severe Atopic Dermatitis

PHASE3CompletedINTERVENTIONAL
Enrollment

941

Participants

Timeline

Start Date

June 27, 2019

Primary Completion Date

December 29, 2021

Study Completion Date

August 11, 2022

Conditions
Moderate-to-Severe Atopic Dermatitis
Interventions
DRUG

Placebo

Placebo

DRUG

Nemolizumab

Nemolizumab

Trial Locations (174)

1090

Galderma Investigational Site 6194, Vienna

1220

Galderma Investigational Site 6158, Vienna

2010

Galderma Investigational Site 5441, Darlinghurst

2145

Galderma Investigational Site 6152, Westmead

2217

Galderma Investigational Site 5759, Kogarah

3002

Galderma Investigational Site 5366, East Melbourne

3050

Galderma Investigational Site 5458, Parkville

3053

Galderma Investigational Site 6131, Carlton

3204

Galderma Investigational Site 6119, Hamilton

4102

Galderma Investigational Site 6161, Brisbane

4217

Galderma Investigational Site 5638, Benowa

5011

Galderma Investigational Site 6159, Woodville

6021

Galderma Investigational Site 6118, Wellington

6100

Galderma Investigational Site 6153, Victoria Park

6160

Galderma Investigational Site 5453, Fremantle

8036

Galderma Investigational Sites 6157, Graz

8907

Galderma Investigational Site 5580, Barcelona

9713

Galderma Investigational Site 6212, Groningen

10023

Galderma Investigational Site 8620, New York

10075

Galderma Investigational Site 8279, New York

11000

Galderma Investigational Site 6021, Prague

11203

Galderma Investigational Site 8242, Brooklyn

12203

Galderma Investigational Site 6172, Berlin

13055

Galderma Investigational Site 6110, Berlin

14584

Galderma Investigational Site 6095, Bucheon-si

15355

Galderma Investigational Site 6098, Gyeonggi-do

18450

Galderma Investigational Site 6154, Gyeonggi-do

19103

Galderma Investigational Site 8255, Philadelphia

19462

Galderma Investigational Site 8802, Plymouth Meeting

21431

Galderma Investigational Site 6138, Incheon

21565

Galderma Investigational Site 6120, Incheon

21614

Galderma Investigational Site 6066, Buxtehude

22031

Galderma Investigational Site 8862, Fairfax

22332

Galderma Investigational Site 6093, Incheon

24105

Galderma Investigational Site 5437, Kiel

28006

Galderma Investigational Site 6058, Madrid

28034

Galderma Investigational Site 5842, Madrid

28046

Galderma Investigational Site 6190, Madrid

28223

Galderma Investigational Site 6036, Madrid

28405

Galderma Investigational Site 8648, Wilmington

28922

Galderma Investigational Site 5551, Madrid

29425

Galderma Investigational Site 8736, Charleston

30263

Galderma Investigational Site 8728, Newnan

30291

Galderma Investigational Site 8887, Union City

31008

Galderma Investigational Site 6191, Pamplona

31217

Galderma Investigational Site 8744, Macon

32256

Galderma Investigational Site 8711, Jacksonville

33014

Galderma Investigational Site 8806, Miami Lakes

33016

Galderma Investigational Site 8804, Hialeah

Galderma Investigational Site 8800, Miami Lakes

33028

Galderma Investigational Site 8734, Pembroke Pines

33122

Galderma Investigational Site 8902, Doral

33126

Galderma Investigational Site 8710, Miami

33145

Galderma Investigational Site 8801, Miami

33174

Galderma Investigational Site 8737, Miami

33176

Galderma Investigational Site 8708, Miami

33511

Galderma Investigational Site 8897, Brandon

33647

Galderma Investigational Site 6061, Bielefeld

33991

Galderma Investigational Site 8805, Cape Coral

35010

Galderma Investigational Site 6106, Las Palmas de Gran Canaria

40241

Galderma Investigational Site 8771, Louisville

43016

Galderma Investigational Site 8595, Dublin

43209

Galderma Investigational Site 8702, Bexley

46250

Galderma Investigational Site 8142, Indianapolis

48084

Galderma Investigational Site 8155, Troy

48109

Galderma Investigational Site 8743, Ann Arbor

48149

Galderma Investigational Site 6039, Münster

48197

Galderma Investigational Site 8748, Ypsilanti

48249

Galderma Investigational Site 6028, Dülmen

48455

Galderma Investigational Site 6022, Bad Bentheim

48706

Galderma Investigational Site 8512, Bay City

49074

Galderma Investigational Site 5918, Osnabrück

49241

Galderma Investigational Site 6100, Busan

57702

Galderma Investigational Site 8818, Rapid City

59808

Galderma Investigational Site 8718, Missoula

60076

Galderma Investigational Site 8571, Skokie

60077

Galderma Investigational Site 8712, Skokie

64283

Galderma Investigational Site 5368, Darmstadt

64506

Galderma Investigational Site 8521, Saint Joseph

68144

Galderma Investigational Site 8810, Omaha

70499

Galderma Investigational Site 6109, Stuttgart

72076

Galderma Investigational Site 6214, Tübingen

72117

Galderma Investigational Site 8880, North Little Rock

73071

Galderma Investigational Site 8206, Norman

73118

Galderma Investigational Site 8857, Oklahoma City

75034

Galderma Investigational Site 8664, Frisco

75230

Galderma Investigational Site 8238, Dallas

76011

Galderma Investigational Site 8133, Arlington

77056

Galderma Investigational Site 8042, Houston

78620

Galderma Investigational Site 8827, Dripping Springs

83221

Galderma Investigational Site 8890, Blackfoot

83687

Galderma Investigational Site 8819, Nampa

89052

Galderma Investigational Site 8740, Henderson

89129

Galderma Investigational Site 6146, Langenau

90025

Galderma Investigational Site 8674, Los Angeles

90404

Galderma Investigational Site 8608, Santa Monica

90703

Galderma Investigational Site 8578, Cerritos

90717

Galderma Investigational Site 8686, Lomita

92703

Galderma Investigational Site 8895, Santa Ana

92708

Galderma Investigational Site 8636, Fountain Valley

92835

Galderma Investigational Site 8888, Fullerton

94115

Galderma Investigational Site 8125, San Francisco

04401

Galderma Investigational Site 8882, Bangor

T2G 1B1

Galderma Investigational Site 8085, Calgary

T2J 7E1

Galderma Investigational Site 8903, Calgary

T3E 0B2

Galderma Investigational Site 8215, Calgary

T5J 3S9

Galderma Investigational Site 8088, Edmonton

T6G 1C3

Galderma Investigational Site 8824, Edmonton

T6G 1C9

Galderma Investigational Site 8722, Edmonton

V3V 0C6

Galderma Investigational Site 8161, Surrey

L4M 7G1

Galderma Investigational Site 8586, Barrie

N1L 0B7

Galderma Investigational Site 8904, Guelph

K1H7X3

Galderma Investigational Site 8901, Ottawa

M3H 5Y8

Galderma Investigational Site 8336, Toronto

M4W 2N4

Galderma Investigational Site 8899, Toronto

L2H 1H5

Galderma Investigational Site 8780, Niagara Falls

K1G 6C6

Galderma Investigational Site 8610, Ottawa

A1C2H5

Galderma Investigational Site 8000, Saint John

N2J 1C4

Galderma Investigational Site 8731, Waterloo

656 91

Galderma Investigational Site 6055, Brno

547 01

Galderma Investigational Site 5225, Náchod

779 00

Galderma Investigational Site 6030, Olomouc

100 00

Galderma Investigational Site 6024, Prague

110 00

Galderma Investigational Site 6054, Prague

120 00

Galderma Investigational Site 6240, Prague

150 06

Galderma Investigational Site 6025, Prague

LV-3401

Galderma Investigational Site 6113, Liepāja

LV-1006

Galderma Investigational Site 6134, Riga

LV-1009

Galderma Investigational Site 6059, Riga

LV-3201

Galderma Investigational Site 6060, Talsi

LT-50161

Galderma Investigational Site 6111, Kaunas

LT-92288

Galderma Investigational Site 6072, Klaipėda

LT-08411

Galderma Investigational Site 6112, Vilnius

3015 GD

Galderma Investigational Site 6108, Rotterdam

3584 CX

Galderma Investigational Site 6027, Utrecht

42-202

Galderma Investigational Site 6255, Częstochowa

80-214

Galderma Investigational Site 6075, Gdansk

80-382

Galderma Investigational Site 6243, Gdansk

80-462

Galderma Investigational Site 5138, Gdansk

81-537

Galderma Investigational Site 6244, Gdynia

40-040

Galderma Investigational Site 6087, Katowice

90-127

Galderma Investigational Site 6245, Lodz

90-265

Galderma Investigational Site 5570, Lodz

94-050

Galderma Investigational Site 6231, Lodz

20-081

Galderma Investigational Site 6071, Lublin

27-400

Galderma Investigational Site 6237, Ostrowiec Świętokrzyski

60-702

Galderma Investigational Site 6127, Poznan

70-332

Galderma Investigational Site 6223, Szczecin

01-192

Galderma Investigational Site 6065, Warsaw

02-507

Galderma Investigational Site 6122, Warsaw

02-793

Galderma Investigational Site 6242, Warsaw

02-953

Galderma Investigational Site 6064, Warsaw

02-962

Galderma Investigational Site 6222, Warsaw

50-381

Galderma Investigational Site 6047, Wroclaw

53-658

Galderma Investigational Site 5005, Wroclaw

02841

Galderma Investigational Site 6105, Seoul

03080

Galderma Investigational Site 5659, Seoul

03722

Galderma Investigational Site 6116, Seoul

04763

Galderma Investigational Site 6129, Seoul

05030

Galderma Investigational Site 6103, Seoul

06591

Galderma Investigational Site 6056, Seoul

06973

Galderma Investigational Site 6094, Seoul

07441

Galderma Investigational Site 6099, Seoul

03010

Galderma Investigational Site 6057, Alicante

08036

Galderma Investigational Site 6037, Barcelona

08916

Galderma Investigational Site 6035, Barcelona

S75 3DL

Galderma Investigational Site 6202, Barnsley

FY2 0JH

Galderma Investigational Site 6207, Blackpool

WS11 0BN

Galderma Investigational Site 6203, Cannock

G3 8SJ

Galderma Investigational Site 6104, Glasgow

L34 1BH

Galderma Investigational Site 6204, Liverpool

SE1 9RT

Galderma Investigational Site 6121, London

M13 9NQ

Galderma Investigational Site 6205, Manchester

TS17 6EW

Galderma Investigational Site 6206, Stockton-on-Tees

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Galderma R&D

INDUSTRY

NCT03985943 - Efficacy and Safety of Nemolizumab in Subjects With Moderate-to-Severe Atopic Dermatitis | Biotech Hunter | Biotech Hunter